channels binding affinity of compounds 1 were investigated. The in vitro activity of compounds 1, 2 and 3 against main cancer cell lines is significant. One of the most active analogs, 1a, had an interesting in vivo anticancer profile against the ovarian cancer cell line IGROV-1, which was associated with an anagelsic activity against the neuropathic pain induced by the main anticancer drugs.
描述了4-(1-
金刚烷基)-4,4-二芳基
丁胺1、5-(1-
金刚烷基)-5,5-二芳基
戊胺2和6-(1-
金刚烷基)-6,6-二芳基
己胺3的合成,并且研究了化合物1的σ1,σ2-受体和
钠通道的结合亲和力。化合物1、2和3对主要癌
细胞系的体外活性是显着的。最活跃的类似物之一1a对卵巢癌
细胞系IGROV-1具有有趣的体内抗癌特性,与抗主要抗癌药引起的神经性疼痛的镇痛活性有关。